Literature DB >> 25660152

Treatment of in-stent restenosis with bioresorbable vascular scaffolds: optical coherence tomography insights.

Fernando Rivero1, Teresa Bastante1, Javier Cuesta1, Amparo Benedicto1, Jorge A Restrepo1, Fernando Alfonso2.   

Abstract

The role of the bioresorbable vascular scaffold (BVS) in patients with in-stent restenosis (ISR) remains unsettled. We present optical coherence tomography (OCT) findings in a series of 15 consecutive patients undergoing treatment of ISR with a BVS under systematic OCT guidance. OCT disclosed severe ISR in all patients (minimal lumen area [MLA], 1.3 ± 0.6 mm(2); stent obstruction 80% ± 10%). After the procedure, OCT MLA was 6.4 ± 2 mm(2) with a final BVS expansion of 79% ± 19%. "Angiographically silent" edge dissections (n = 6), intradevice dissections (n = 3), tissue prolapse (n = 3), and malapposition (n = 3) were also readily visualized. These findings underscore the diagnostic value of OCT in patients undergoing BVS implantation for ISR.
Copyright © 2015 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25660152     DOI: 10.1016/j.cjca.2014.11.017

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  7 in total

1.  Challenging treatment of in-stent restenosis in a coronary bifurcation by implantation of a bioresorbable scaffold under optical coherence tomography guidance.

Authors:  Grzegorz Zuk; Dariusz Ciecwierz; Piotr Drewla; Marcin Gruchała; Juan Luis Gutiérrez-Chico; Milosz Jaguszewski
Journal:  Cardiol J       Date:  2019       Impact factor: 2.737

Review 2.  Therapeutic Options for In-Stent Restenosis.

Authors:  Charles Nicolais; Vladimir Lakhter; Hafeez Ul Hassan Virk; Partha Sardar; Chirag Bavishi; Brian O'Murchu; Saurav Chatterjee
Journal:  Curr Cardiol Rep       Date:  2018-02-12       Impact factor: 2.931

3.  Post-dilatation after implantation of bioresorbable everolimus- and novolimus-eluting scaffolds: an observational optical coherence tomography study of acute mechanical effects.

Authors:  Florian Blachutzik; Niklas Boeder; Jens Wiebe; Alessio Mattesini; Oliver Dörr; Astrid Most; Timm Bauer; Jens Röther; Monique Tröbs; Christian Schlundt; Stephan Achenbach; Christian W Hamm; Holger M Nef
Journal:  Clin Res Cardiol       Date:  2016-10-18       Impact factor: 5.460

4.  All-comer treatment with bioresorbable vascular scaffold.

Authors:  Matjaž Bunc; Miha Mrak; Peter Rakovec
Journal:  Wien Klin Wochenschr       Date:  2016-01-25       Impact factor: 1.704

Review 5.  Current Management of In-Stent Restenosis.

Authors:  Ae Young Her; Eun Seok Shin
Journal:  Korean Circ J       Date:  2018-05       Impact factor: 3.243

Review 6.  Intravascular imaging in coronary stent restenosis: Prevention, characterization, and management.

Authors:  Amr Abouelnour; Tommaso Gori
Journal:  Front Cardiovasc Med       Date:  2022-08-09

7.  Thirty-Day and One-Year Clinical Outcomes of Bioresorbable Vascular Scaffold Implantation: A Single-Center Experience.

Authors:  Wei-Chieh Lee; Chiung-Jen Wu; Chien-Jen Chen; Cheng-Hsu Yang; Shu-Kai Hsueh; Hon-Kan Yip; Chi-Ling Hang; Chih-Yuan Fang; Hsiu-Yu Fang
Journal:  Acta Cardiol Sin       Date:  2017-11       Impact factor: 2.672

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.